Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Anavex Life Sciences Corp...

    NASDAQ: AVXL · Real-Time Price · USD
    9.69
    -0.26 (-2.56%)
    At close: Aug 18, 2025, 3:02 PM

    Anavex Life Sciences Cash Flow Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
    Net Income
    		 -13.24M -11.2M -12.11M -11.62M -12.21M -10.55M -8.62M -10.15M -11.28M -13.11M -12.97M -14.29M -12.37M -10.44M -10.88M -11.72M -10.18M -8.16M -7.86M
    Depreciation & Amortization
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Stock-Based Compensation
    		 4.32M 1.45M 2.06M 2.01M 2.49M 2.65M 2.29M 3.19M 3.87M 3.97M 5.35M 6.04M 3.99M 4.44M 3.91M 3.15M 2.29M 1.85M 939.31K
    Other Working Capital
    		 -5.4M 1.83M 3.1M -2.45M 2.71M -2.96M 30K 1.48M 1.89M -1.19M 367.47K 3.51M 830.23K -1.64M 3.58M 328.62K -153.38K -448.88K -1.18M
    Other Non-Cash Items
    		 n/a n/a n/a 59K -59K n/a n/a 500.00 3.42M 845K 4.78M 1.98M 3.58M 7.54M 249.09K 3.12M 3.05M 1.85M 227.89K
    Deferred Income Tax
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Change in Working Capital
    		 -3.54M 3.89M -2.06M 2.89M 4.61M -3.76M -982K 1.11M -239.34K -197K 1.83M 4.2M 1.33M -3.64M 3.47M 891.69K 365.27K -1.01M -955.63K
    Operating Cash Flow
    		 -12.46M -5.86M -12.12M -6.66M -5.18M -11.66M -7.32M -5.85M -7.65M -8.49M -5.79M -4.04M -7.05M -9.64M -3.5M -7.67M -7.52M -7.32M -7.87M
    Capital Expenditures
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Investing Cash Flow
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Debt Repayment
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Financial Acitivies
    		 -2.26M n/a n/a 4.2M 444K n/a n/a 868.34K n/a 181.5K -243 -75 327.91K -251.3K 226.78K 2.22M -2.06M 127.56K -263.46K
    Financial Cash Flow
    		 -2.14M 852K 708K 89K 4.55M 7.28M 59K 2.06M 9M 18.33M 258.24K 2.44K 6.91M 11.84M 2.54M 2.22M 89.22M 35.82M 25.98M
    Net Cash Flow
    		 -14.61M -5M -11.41M -6.57M -630K -4.38M -7.26M -3.79M 1.35M 9.85M -5.54M -4.04M -143.2K 2.2M -961.39K -5.45M 81.7M 28.5M 18.11M
    Free Cash Flow
    		 -12.46M -5.86M -12.12M -6.66M -5.18M -11.66M -7.32M -5.85M -7.65M -8.49M -5.79M -4.04M -7.05M -9.64M -3.5M -7.67M -7.52M -7.32M -7.87M

    Add to Watchlist